For example, human epidermal growth factor receptor-2+ (HER-2+) breast cancer and TNBC are more likely to have interstitial infiltrating immune cells (TILs), than luminal breast cancer, and there is a linear relationship between the TILs content and clinical results. Here, ERBB2 is linked to breast cancer.